Asia Pacific Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End User (Hospitals, Clinical Labs) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Antinuclear Antibody Test Market By Disease (SLE, Rheumatoid Arthritis), By Technique (Immunofluorescence, Multiplex, ELISA), By Product (Software, Systems, Services, Reagents & Assay Kits), By End User (Hospitals, Clinical Labs) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 3303 | Pages: 149 | September 2017 | Region: Asia Pacific


The Asia Pacific Antinuclear Antibody Test Market was worth USD 148.23 million in 2016 and expected to reach USD 280.43 million by 2021 at a CAGR of 13.60%. The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.

Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, growing economies in this region and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. Other factors such as an increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.

The Asia Pacific Antinuclear Antibody Test Market is broadly categorized on the basis of Disease, Technique, Product, and End-Users. On the basis of Disease, it is further sub-categorized into Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis. On the basis of Technique, it is segmented into Immunofluorescence, Multiplex, and ELISA. On the basis of Product, it is divided into Software, Systems, Services, and Reagents & Assay Kits. It is divided into Hospitals, and Clinical Labs on the basis of End-Users. As of 2016, Assay Kits & reagents segment accounts for the largest share of Asia-Pacific ANA testing market. It can be because of the growth in a number of reagent rental agreements. On the basis of Diseases, Rheumatoid Arthritis is expected to have the largest share in the market until the end of the forecast period due to the increased incidences of rheumatoid arthritis. ELISA is currently leading the market on the basis of the technique used for testing.

Geographically, Asia Pacific Antinuclear Antibody Test Market is segmented into India, China, North Korea, Japan and Australia. Of all these regions, China and India have the biggest market share mainly because of the huge population in these regions. Japan is showing great potential in terms of growth rate.

Some of the major companies dominating the market, by their products and services include Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Disease                        

                                5.1.1 Introduction           

                                5.1.2 SLE              

                                5.1.3 Rheumatoid Arthritis          

                                5.1.4  Y-o-Y Growth Analysis, By Disease               

                                5.1.5  Market Attractiveness Analysis, By Disease             

                                5.1.6  Market Share Analysis, By Disease              

                5.2 Technique                   

                                5.2.1 Introduction           

                                5.2.2 Immunofluorescence         

                                5.2.3 Multiplex 

                                5.2.4 ELISA         

                                5.2.5 Y-o-Y Growth Analysis, By Technique          

                                5.2.6 Market Attractiveness Analysis, By Technique        

                                5.2.7 Market Share Analysis, By Technique          

                5.3 Product                        

                                5.3.1 Introduction           

                                5.3.2 Software  

                                5.3.3 Systems   

                                5.3.4 Services    

                                5.3.5 Reagents & Assay Kits        

                                5.3.6 Y-o-Y Growth Analysis, By Product               

                                5.3.7  Market Attractiveness Analysis, By Product            

                                5.3.8  Market Share Analysis, By Product              

                5.4 End-User                     

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Labs             

                                5.4.4 Y-o-Y Growth Analysis, By End-User            

                                5.4.5  Market Attractiveness Analysis, By End-User         

                                5.4.6  Market Share Analysis, By End-User           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Disease

                                                6.1.3.3 By Technique

                                                6.1.3.4 By Product

                                                6.1.3.5 By End-User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Disease

                                                6.1.4.3 By Technique

                                                6.1.4.4 By Product

                                                6.1.4.5 By End-User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Disease

                                                6.1.5.3 By Technique

                                                6.1.5.4 By Product

                                                6.1.5.5 By End-User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Zeus Scientific Inc.                   

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Inova Diagnostics                     

                8.3 Immuno Concepts                   

                8.4 Euroimmun AG                         

                8.5 Antibodies Inc.                          

                8.6 Thermo Fisher Scientific Inc.                               

                8.7 Trinity Biotech plc                    

                8.8 ERBA Diagnostics Inc.                             

                8.9 Bio-Rad Laboratories Inc.                      

                8.10 Alere Inc.                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  2. Asia-Pacific SLE Market By Region, From 2016-2021 ( USD Million )
  3. Asia-Pacific Rheumatoid Arthritis Market By Region, From 2016-2021 ( USD Million )
  4. Asia-Pacific Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  5. Asia-Pacific Immunofluorescence Market By Region, From 2016-2021 ( USD Million )
  6. Asia-Pacific Multiplex Market By Region, From 2016-2021 ( USD Million )
  7. Asia-Pacific ELISA Market By Region, From 2016-2021 ( USD Million )
  8. Asia-Pacific Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  9. Asia-Pacific Software Market By Region, From 2016-2021 ( USD Million )
  10. Asia-Pacific Systems Market By Region, From 2016-2021 ( USD Million )
  11. Asia-Pacific Services Market By Region, From 2016-2021 ( USD Million )
  12. Asia-Pacific Reagents & Assay Kits Market By Region, From 2016-2021 ( USD Million )
  13. Asia-Pacific Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
  14. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  15. Asia-Pacific Clinical Labs Market By Region, From 2016-2021 ( USD Million )
  16. Japan Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  17. Japan Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  18. Japan Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  19. Japan Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
  20. China Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  21. China Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  22. China Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  23. China Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
  24. India Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  25. India Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  26. India Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  27. India Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
  28. Australia Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  29. Australia Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  30. Australia Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  31. Australia Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
  32. South Korea Antinuclear Antibody Testing Market By Disease, From 2016-2021 ( USD Million )
  33. South Korea Antinuclear Antibody Testing Market By Technique, From 2016-2021 ( USD Million )
  34. South Korea Antinuclear Antibody Testing Market By Product, From 2016-2021 ( USD Million )
  35. South Korea Antinuclear Antibody Testing Market By End-Users, From 2016-2021 ( USD Million )
Middle East And Africa Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridizat...
Latin America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Asia Pacific Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End ...
Europe Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (...
North America Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End...
Infectious Diseases Diagnostics Market By Product (Instruments, Reagents, Services, Software), Application (Hepatitis C, AIDS, Tuberculosis), Technology (PCR, INAAT, DNA Sequencing, Hybridization), End User (Hospita...
Middle East And Africa RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray...
Latin America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
Asia Pacific RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNA...
Europe RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By...
North America RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RN...
RNA Analysis Market By Application (Drug Discovery, Clinical Diagnostics, Toxic Genomics), By End-User (Pharmaceutical And Biotech Companies, Academic Research), By Technology (PCR, Microarray, NGS, RNAi), By Region...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.